INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 121 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,412 | +135200.0% | 25,649 | -2.6% | 0.00% | – |
| Q1 2023 | $4 | -71.4% | 26,343 | +4.5% | 0.00% | -100.0% |
| Q4 2022 | $14 | -99.9% | 25,216 | +14.2% | 0.00% | – |
| Q3 2022 | $26,000 | +136.4% | 22,076 | +28.1% | 0.00% | – |
| Q2 2022 | $11,000 | 0.0% | 17,237 | +83.9% | 0.00% | – |
| Q1 2022 | $11,000 | -87.1% | 9,375 | -75.3% | 0.00% | -100.0% |
| Q4 2021 | $85,000 | +400.0% | 37,936 | +673.3% | 0.00% | – |
| Q3 2021 | $17,000 | +6.2% | 4,906 | -5.7% | 0.00% | – |
| Q2 2021 | $16,000 | -84.0% | 5,202 | -83.3% | 0.00% | -100.0% |
| Q1 2021 | $100,000 | +203.0% | 31,120 | +101.8% | 0.00% | +100.0% |
| Q4 2020 | $33,000 | – | 15,419 | +90600.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 17 | -99.9% | 0.00% | -100.0% |
| Q4 2019 | $11,000 | +266.7% | 11,829 | +379.7% | 0.00% | – |
| Q3 2019 | $3,000 | -40.0% | 2,466 | -8.8% | 0.00% | – |
| Q1 2019 | $5,000 | -16.7% | 2,703 | -50.4% | 0.00% | – |
| Q4 2018 | $6,000 | +500.0% | 5,448 | +1307.8% | 0.00% | – |
| Q1 2018 | $1,000 | -66.7% | 387 | -76.7% | 0.00% | – |
| Q4 2017 | $3,000 | – | 1,664 | – | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q2 2017 | $56,000 | +80.6% | 35,653 | +53.9% | 0.01% | +100.0% |
| Q2 2016 | $31,000 | +287.5% | 23,159 | +1443.9% | 0.00% | +200.0% |
| Q1 2016 | $8,000 | -61.9% | 1,500 | -43.5% | 0.00% | -66.7% |
| Q4 2015 | $21,000 | +23.5% | 2,655 | +33.8% | 0.00% | +50.0% |
| Q3 2015 | $17,000 | -86.9% | 1,984 | -83.3% | 0.00% | -83.3% |
| Q2 2015 | $130,000 | +4.8% | 11,845 | +33.0% | 0.01% | -20.0% |
| Q1 2015 | $124,000 | +1966.7% | 8,905 | +2359.9% | 0.02% | +1400.0% |
| Q4 2014 | $6,000 | +500.0% | 362 | +262.0% | 0.00% | – |
| Q3 2014 | $1,000 | -94.7% | 100 | -93.8% | 0.00% | -100.0% |
| Q1 2014 | $19,000 | +216.7% | 1,623 | +305.8% | 0.00% | +100.0% |
| Q4 2013 | $6,000 | -85.7% | 400 | -83.2% | 0.00% | -80.0% |
| Q3 2013 | $42,000 | -70.8% | 2,375 | -73.3% | 0.01% | -58.3% |
| Q2 2013 | $144,000 | – | 8,888 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,575,000 | $21,237,000 | 2.26% |
| AIGH Capital Management LLC | 1,650,256 | $5,330,000 | 1.12% |
| BVF INC/IL | 8,383,645 | $27,079,000 | 1.02% |
| GUARDIAN POINT CAPITAL, LP | 1,200,000 | $3,876,000 | 0.97% |
| Tri Locum Partners LP | 1,210,863 | $3,911,000 | 0.97% |
| Altium Capital Management LP | 972,327 | $3,141,000 | 0.87% |
| Worth Venture Partners, LLC | 387,141 | $1,250,000 | 0.61% |
| DAFNA Capital Management LLC | 459,260 | $1,483,000 | 0.35% |
| SABBY MANAGEMENT, LLC | 530,000 | $1,712,000 | 0.33% |
| KNIGHTSBRIDGE ASSET MANAGEMENT, LLC | 173,110 | $559,000 | 0.24% |